Cannabidiol is distinct from marijuana, as by definition, it contains no more than 0.3% THC. The CBD industry has skyrocketed over the past several years, with recent profit projections suggesting that the substance will soon exceed a billion dollars in net earnings. Several major points of progress have punctuated the substance’s growth across the United States – with the most recent industry development happening in Coloradoans’ own backyard.
Our writers previously covered the incredible story of Charlotte Figi, whose parents claim she owes her life to the use of CBD extracts. They originally attempted the use of CBD as a last-resort while grasping at straws to save their young daughter, whose 300 weekly grand mal seizures rendered her physically incapacitated and severely stunted in terms of developmental growth by the age of five. Doctors originally suggested a medically-induced coma to prevent further brain damage if Charlotte’s presenting symptoms failed to improve with other courses of treatment. Following her usage of a carefully chosen CBD extract as a core component of her treatment regiment, the frequency of Charlotte’s seizures quickly diminished to almost non-existent. The substance which allegedly alleviated Charlotte’s symptoms to such an extreme degree has since been dubbed “Charlotte’s Web.”
Claims of community members who believed that CBD has aided their symptoms increasingly became more frequent, prompting the response of industry leaders. One major CBD industry milestone was the FDA’s usage of CBD in a recently developed drug called Epidiolex. This substance contains a purified, refined version of cannabidiol. Epidiolex, which is approved for patients above the age of two, is intended to relieve the symptoms of seizures and other debilitating symptoms associated with Lennox-Gastaut syndrome, a rare but similar affliction to the one which gripped young Charlotte’s life prior to her treatment.
The most recent development worth noting – especially for Coloradoans - comes from the Denver suburb of Broomfield. Mile High Labs recently purchased a large production facility from Sandoz Incorporated, a subsidiary of the large pharmaceutical company Novartis. This $18.75 million purchase secured 400,000 square feet of development space in Broomfield for Mile High Labs.
Christopher Lackner represents Mile High Labs as the corporation’s vice president. In a recent interview on their recent acquisition, he spoke to Colorado’s pioneering influence in the booming cannabidiol industry. "Colorado is one of the leading states in promoting and encouraging hemp production, agriculture and innovation, and with our new facility here producing CBD isolate, CBD distillate and other products, we feel like this is really the center of the CBD universe."
Mile High Labs is far from the only company to embrace this new line of products, and concurrently push for improvements in remaining legislative hiccups and federal research funding. In fact, Mile High Labs recently sent several of their top representatives to Washington D.C. to speak with Colorado’s congressional delegate.
This expansive facility - with a size equivalent to nearly seven football fields - gives Mile High Labs all the space they need to expand, locally and across America.
While Mile High Labs expands their repoitoire in the rocky mountains, they're not the only company to gain traction in exciting local industries on the rise. Our products all contain phytocannabinoid-rich, broad spectrum hemp extract and can be delivered right to your doorstep. All five flavors of our hemp CBD beverages are delicious and refreshing. Better yet, each sparkling CBD soda flavor is vegan, non-GMO, and free of gluten, sodium, and preservatives. PCR hemp extract is one of just five ingredients in every sparkling CBD soda can, and you’ll taste that sweet simplicity with every sip.